Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sleep-disordered breathing in multiple sclerosis.
Plasma chemerin levels in patients with multiple sclerosis.
Effects of functional electrical stimulation on gait function and quality of life for people with multiple sclerosis taking dalfampridine.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
The safety of exercise training in multiple sclerosis: A systematic review.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.
Condition-specific preference-based measures: benefit or burden?
Functional identification of neural stem cell-derived oligodendrocytes.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Daily hassles reported by Dutch multiple sclerosis patients.
Multiple sclerosis and stress.
Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications.
A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption.
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis.
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
Pages
« first
‹ previous
…
185
186
187
188
189
190
191
192
193
…
next ›
last »